Without a clear and reliable strategy for commercialisation external from token health investors are missing out on longer term profitability. Although token speculation is a key driver for early stage growth and ROI, we use an incubation model that provides a much higher potential of continuous growth regardless of market cycle phases, that supports price stability within the token ecosystem and gives clear routes to revenue models that are independent of speculative price discovery. Our cohort companies are built with commercialisation in mind.